NO20060498L - Metode for a promotere benvekst - Google Patents

Metode for a promotere benvekst

Info

Publication number
NO20060498L
NO20060498L NO20060498A NO20060498A NO20060498L NO 20060498 L NO20060498 L NO 20060498L NO 20060498 A NO20060498 A NO 20060498A NO 20060498 A NO20060498 A NO 20060498A NO 20060498 L NO20060498 L NO 20060498L
Authority
NO
Norway
Prior art keywords
bone growth
promoting bone
calcium
patient
phosphorus
Prior art date
Application number
NO20060498A
Other languages
English (en)
Inventor
Jill Marie Jobbins
Original Assignee
Rhodia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodia filed Critical Rhodia
Publication of NO20060498L publication Critical patent/NO20060498L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Metode for behandling av en pasient for å fremme benvekst, som omfatter: å administrere til pasienten en terapeutisk mengde av et benremodelleringsmiddel som effektivt stimulerer benvekst, og et kosttilskudd som omfatter kalsium og fosfor, i en terapeutisk mengde som effektivt forebygger underskudd av den mengde kalsium eller fosfor som er tilgjengelig for benvekst.
NO20060498A 2003-08-06 2006-01-31 Metode for a promotere benvekst NO20060498L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49288203P 2003-08-06 2003-08-06
PCT/US2004/024792 WO2005016265A2 (en) 2003-08-06 2004-08-02 Method for promoting bone growth

Publications (1)

Publication Number Publication Date
NO20060498L true NO20060498L (no) 2006-02-24

Family

ID=34193155

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060498A NO20060498L (no) 2003-08-06 2006-01-31 Metode for a promotere benvekst

Country Status (10)

Country Link
US (1) US20050037089A1 (no)
EP (1) EP1651246A4 (no)
JP (1) JP2007501241A (no)
KR (1) KR20060056975A (no)
AU (1) AU2004264899A1 (no)
CA (1) CA2534577A1 (no)
IL (1) IL173485A0 (no)
MX (1) MXPA06001428A (no)
NO (1) NO20060498L (no)
WO (1) WO2005016265A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2628945A1 (en) * 2005-11-10 2007-05-24 Board Of Control Of Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US8974801B2 (en) * 2006-12-21 2015-03-10 Amphastar Pharmaceuticals Inc. Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
CN104605359A (zh) * 2008-06-16 2015-05-13 N·V·努特里奇亚 具有脂肪梯度的组合物
WO2010027259A1 (en) * 2008-09-02 2010-03-11 N.V. Nutricia Nutritional compositions with coated lipid globules
US9603876B2 (en) * 2008-09-25 2017-03-28 New York University Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
WO2010068086A1 (en) * 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
BR112012013725A2 (pt) 2009-12-07 2017-01-10 Univ Michigan Tech paratormônio de urso preto e métodos de usar o paratormônio de uso preto.
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
US8501690B2 (en) * 2010-04-30 2013-08-06 John G. Stark Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue
US8951512B2 (en) * 2010-05-04 2015-02-10 New York University Methods for treating bone disorders by characterizing and restoring mammalian bacterial microbiota
US9386793B2 (en) 2010-08-20 2016-07-12 New York University Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
BR112015023023B1 (pt) * 2013-03-14 2021-04-27 Amip, Llc Composição nutricional para suplementação de cálcio e de fósforo
ES2693519T3 (es) 2013-11-01 2018-12-12 N.V. Nutricia Composición lipídica para mejorar la composición corporal durante el crecimiento de recuperación
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
US9855305B2 (en) 2016-03-29 2018-01-02 Companion Therapeutics Llc Pharmaceutical composition containing combinations of vitamins, minerals, probiotics, and prebiotics effective in preventing adverse effects associated with the use of proton-pump inhibitors
US10653728B2 (en) 2016-10-17 2020-05-19 New York University Probiotic compositions for improving metabolism and immunity
ES2987545T3 (es) 2016-12-09 2024-11-15 Nutricia Nv Composición nutricional para su uso en la mejora del rendimiento cognitivo y/o la prevención del deterioro cognitivo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78342A (en) * 1985-04-04 1991-06-10 Gen Hospital Corp Pharmaceutical composition for treatment of osteoporosis in humans comprising a parathyroid hormone or a fragment thereof
RU2112515C1 (ru) * 1991-12-17 1998-06-10 Проктер энд Гэмбл Фармасьютикалз, Инк. Способ лечения остеопороза
CN1120314A (zh) * 1993-04-02 1996-04-10 加利福尼亚大学董事会 治疗骨质疏松症的方法和组合物
US5763416A (en) * 1994-02-18 1998-06-09 The Regent Of The University Of Michigan Gene transfer into bone cells and tissues
US5723577A (en) * 1995-07-13 1998-03-03 Biomeasure Inc. Analogs of parathyroid hormone
US5955574A (en) * 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
JP3742523B2 (ja) * 1998-02-27 2006-02-08 雪印乳業株式会社 高分子型カルシウム・ホスホペプチド複合体
US6447809B1 (en) * 1999-05-11 2002-09-10 Metagenics, Inc. Composition for promoting healthy bone structure
JP5100923B2 (ja) * 2000-02-16 2012-12-19 雪印メグミルク株式会社 カルシウム・リン酸化澱粉複合体及びその製造方法
US20040137072A1 (en) * 2003-01-13 2004-07-15 Richard Cockrum Method for increasing calcium absorption and bone mineral density through the supplementation of bovine colostrum

Also Published As

Publication number Publication date
EP1651246A2 (en) 2006-05-03
IL173485A0 (en) 2006-06-11
JP2007501241A (ja) 2007-01-25
EP1651246A4 (en) 2009-06-24
WO2005016265A3 (en) 2005-07-07
US20050037089A1 (en) 2005-02-17
WO2005016265A2 (en) 2005-02-24
MXPA06001428A (es) 2006-05-15
CA2534577A1 (en) 2005-02-24
AU2004264899A1 (en) 2005-02-24
KR20060056975A (ko) 2006-05-25

Similar Documents

Publication Publication Date Title
NO20060498L (no) Metode for a promotere benvekst
DE60115842D1 (de) Ventilanordnung
DE502007002101D1 (de) Arzneimittel mit Dobesilat-Calcium zur Behandlung und Prophylaxe von Sehnenerkrankungen
NO20042151L (no) Sammensetning for a forbedre skjelettvekst og opprettholdelse av benhelse
EE05419B1 (et) Asendatud oksasolidinoonid kombineeritud raviks
TW200612987A (en) Combination treatment for non-hematologic malignancies
BRPI0519178A2 (pt) composiÇço de cuidado oral, e, mÉtodo de prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
EP1670450A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHOD OF USING LEVODOPA AND CARBIDOPA
MX2010006519A (es) Metodo para tratar una fractura de hueso con anticuerpos anti-esclerostina.
PT1677806E (pt) Métodos para tratamento de entorse e distensão muscular aguda e por excesso de esforço utilizando ácido hialurónico
ATE380554T1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
NO20060912L (no) Preoperativ behandling for postoperativ smerte
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
BR0111900A (pt) Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
BRPI0507302A (pt) método e composições para o tratamento da lipodistrofia
RU2008150987A (ru) Способ лечения переломов длинных трубчатых костей
WO2004024083A3 (en) Methods of bone healing
DE60236894D1 (de) Behandlung von statin-nebenwirkungen mit uridinderivaten
UA33571A (uk) Спосіб лікування травматичного перелому нижньої щелепи
ATE403424T1 (de) Verwendung von zinkgluconat zur behandlung von hydradenitis suppurativa
TW200519078A (en) 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture
UA34163A (uk) Спосіб стимулювання остеогенезу при хірургічних втручаннях на кістках щелепи

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application